These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3168069

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New trends in the chemotherapy of staphylococcal infections.
    Russo G, Tempera G, Stefani S, Nicoletti G.
    Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of some Staphylococcus species to aminoglycosides.
    Geraci C, Stefani S, Focà A, Stassi G, Varaldo PE, Cipriani P, Giordano A.
    Chemioterapia; 1985 Dec; 4(6):436-8. PubMed ID: 3854285
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Synergy between tobramycin and netilmicin on three strains of methicillin and gentamicin resistant staphylococci (S. epidermidis, S. aureus)].
    Ratovohery D, Assous MV, Gilly L, Brun T, Nevot P, Paul G.
    Ann Med Interne (Paris); 1994 Dec; 145(4):234-7. PubMed ID: 8092647
    [Abstract] [Full Text] [Related]

  • 6. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
    David C, Chaste A, Saison C, Combremont AG.
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
    [Abstract] [Full Text] [Related]

  • 7. In vitro study of dactimicin (ST 900) against methicillin-susceptible and -resistant staphylococci.
    Stefani S, Mezzatesta M, Oliveri S, Nicolosi VM, Russo G.
    Chemioterapia; 1987 Aug; 6(4):264-8. PubMed ID: 3652276
    [Abstract] [Full Text] [Related]

  • 8. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Husson MO, Izard D, Leclerc H.
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
    [Abstract] [Full Text] [Related]

  • 9. Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
    Husson MO, Izard D, Bryskier A, Vincent P, Leclerc H.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):383-7. PubMed ID: 6091368
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A, Montini G, Ramacciotti PG.
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [Abstract] [Full Text] [Related]

  • 12. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC, Exner GU, Reize CL, Merkofer C, Scott CP, Zbinden R.
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
    Husson MO, Izard D, Leclerc H.
    Drugs Exp Clin Res; 1986 Apr; 12(4):325-7. PubMed ID: 3459642
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I, Voeckl J, Machka K.
    Arzneimittelforschung; 1980 Apr; 30(3):491-5. PubMed ID: 7387761
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic and genotypic aminoglycoside resistance in blood culture isolates of coagulase-negative staphylococci from a single neonatal intensive care unit, 1989-2000.
    Klingenberg C, Sundsfjord A, Rønnestad A, Mikalsen J, Gaustad P, Flaegstad T.
    J Antimicrob Chemother; 2004 Nov; 54(5):889-96. PubMed ID: 15471996
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
    Cafiso V, Messina C, Santagati M, Campanile F, Bonfiglio G, Stefani S.
    Drugs Exp Clin Res; 2001 Nov; 27(3):107-11. PubMed ID: 11447768
    [Abstract] [Full Text] [Related]

  • 17. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital.
    Schreckenberger PC, Ilendo E, Ristow KL.
    J Clin Microbiol; 2004 Jun; 42(6):2777-9. PubMed ID: 15184468
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial resistance in coagulase-negative staphylococci.
    Hamilton-Miller JM, Iliffe A.
    J Med Microbiol; 1985 Apr; 19(2):217-26. PubMed ID: 3845121
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
    Alou L, Cafini F, Sevillano D, Unzueta I, Prieto J.
    Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734
    [Abstract] [Full Text] [Related]

  • 20. [Susceptibility to cefazolin, cefamandole and ceftazidime in Staphylococcus strains].
    Wiktorowicz-Belzyt E, Wojak I, Janicka G.
    Med Dosw Mikrobiol; 1997 May; 49(1-2):35-43. PubMed ID: 9411070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.